Apr 04, 2012 12:00am EDT Pieris Presents Preclinical Data for PRS-110 c-Met Antagonist Anticalin® at the AACR Annual Meeting
Feb 07, 2012 12:00am EST Pieris Receives BMBF Grant to Fund PRS-110 c-Met Antagonist Anticalin® Program
Dec 13, 2011 12:00am EST Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin® Program at ASH Annual Meeting
Nov 15, 2011 12:00am EST Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference
Oct 19, 2011 12:00am EDT EUROCALIN Consortium Initiates EU Grant Funded Collaboration to Develop Novel Anticalin Therapeutic to Treat Anemia
Oct 19, 2011 12:00am EDT Pieris Outlines Strategic Impact of Six Million Euro EUROCALIN Grant Award on Anticalin® Pipeline Development
May 23, 2011 12:00am EDT Pieris Announces Preclinical In Vitro and In Vivo Data for its Anticalin® PRS-080 Hepcidin Antagonist Drug Program
Apr 12, 2011 12:00am EDT Pieris and Daiichi Sankyo Sign Therapeutic Collaboration to Develop Anticalin® Therapeutics
Apr 11, 2011 12:00am EDT Pieris to Present at BioCentury Future Leaders in the Biotech Industry Conference
Feb 22, 2011 12:00am EST Pieris to Present Interim Date from the Phase I Clinical Trial of PRS-050 at Molecular Medicine Tri-Conference